Article Details

Adaptimmune Therapeutics (NASDAQ:ADAP) PT Lowered to $6.00

Retrieved on: 2019-05-16 23:33:45

Tags for this article:

Click the tags to see associated articles and topics

Adaptimmune Therapeutics (NASDAQ:ADAP) PT Lowered to $6.00. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> boosted its position in shares of Adaptimmune Therapeutics by 28.2% in the first quarter. <b>Man Group plc</b> now owns 1,338,630 shares of ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo